Astria Therapeutics (ATXS) Change in Cash: 2013-2024
Historic Change in Cash for Astria Therapeutics (ATXS) over the last 12 years, with Dec 2024 value amounting to -$115.9 million.
- Astria Therapeutics' Change in Cash fell 63.73% to -$7.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$5.0 million, marking a year-over-year decrease of 368.00%. This contributed to the annual value of -$115.9 million for FY2024, which is 174.75% down from last year.
- As of FY2024, Astria Therapeutics' Change in Cash stood at -$115.9 million, which was down 174.75% from $155.0 million recorded in FY2023.
- Astria Therapeutics' 5-year Change in Cash high stood at $155.0 million for FY2023, and its period low was -$115.9 million during FY2024.
- Over the past 3 years, Astria Therapeutics' median Change in Cash value was -$65.9 million (recorded in 2022), while the average stood at -$8.9 million.
- Per our database at Business Quant, Astria Therapeutics' Change in Cash skyrocketed by 391.69% in 2020 and then slumped by 207.09% in 2022.
- Astria Therapeutics' Change in Cash (Yearly) stood at $14.7 million in 2020, then skyrocketed by 319.61% to $61.6 million in 2021, then slumped by 207.09% to -$65.9 million in 2022, then surged by 335.07% to $155.0 million in 2023, then tumbled by 174.75% to -$115.9 million in 2024.